UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052304
Receipt number R000059701
Scientific Title Assessment of flavonoid Pharmacokinetics following single capsule intake in healthy adult men
Date of disclosure of the study information 2023/09/25
Last modified on 2024/07/31 15:30:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of flavonoid Pharmacokinetics following single capsule intake in healthy adult men

Acronym

Assessment of flavonoid Pharmacokinetics following single capsule intake in healthy adult men

Scientific Title

Assessment of flavonoid Pharmacokinetics following single capsule intake in healthy adult men

Scientific Title:Acronym

Assessment of flavonoid Pharmacokinetics following single capsule intake in healthy adult men

Region

Japan


Condition

Condition

Healthy individuals

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Obtaining fundamental information on flavonoid pharmacokinetics after single capsule intake in healthy adult men

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Flavonoid plasma kinetics parameters

Key secondary outcomes

(Secondary outcomes)
Urinary flavonoid excretion rate
(Safety evaluation)
Frequency of adverse events during the period from intake of the test food to the following day, general physical findings (subjective symptoms, objective findings), vital signs (body weight, body temperature, blood pressure, pulse rate), blood test items, urinalysis items


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Test food 1 (single ingestion) -Washout period-Test food 2 (single ingestion)

Interventions/Control_2

Test food 2 (single ingestion) -Washout period-Test food 1 (single ingestion)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male

Key inclusion criteria

1)Individuals who voluntarily giving written informed consent.
2)Healthy adult males aged between 20 and 60.
3)Individuals able to intake the test food (capsule).
4)Individuals who can intake test foods, etc., take blood samples, take urine samples, and stay quiet and rest on the schedule indicated by investigators.

Key exclusion criteria

1)Individuals whose clinical inspection results are outside of the normal range and who are estimated inappropriate to this study by principal investigator.
2)Individuals with current or previous disorders of the gastrointestinal, cardiovascular, and endocrine systems who are determined to be ineligible for the study by the investigator.
3)Individuals with smoking habits.
4)As a general rule, individuals who regularly use medicines for treatnemnt of diseases.
5)Individuals with food allergy.
6)Individuals who are currently participating in another study or plan to participate during the study period
7)Individuals who are estimated inappropriate to participate to this study by principal investigator.

Target sample size

18


Research contact person

Name of lead principal investigator

1st name Yasutaka
Middle name
Last name Ikeda

Organization

Otsuka Pharmaceutical Co., Ltd.

Division name

Otsu Nutraceuticals Research Institute

Zip code

520-0002

Address

3-31-13 Saigawa, Otsu, Shiga, Japan

TEL

077-521-8835

Email

Ikeda.Yasutaka@otsuka.jp


Public contact

Name of contact person

1st name Hidemasa
Middle name
Last name Toya

Organization

HUMA R&D CORP

Division name

Clinical Development Department

Zip code

108-0014

Address

Round Cross Tamachi 9F, 5-31-19 Shiba, Minato-ku, Tokyo 108-0014 Japan

TEL

03-3431-1260

Homepage URL


Email

toya@huma-rd.co.jp


Sponsor or person

Institute

Otsuka Pharmaceutical Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Otsuka Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Miyake Clinic Institutional Review Board

Address

4-2-17 Komagome, Toshima-ku, Tokyo 170-0003 Japan

Tel

03-6903-7211

Email

jim@medipharma.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 09 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

18

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 09 Month 06 Day

Date of IRB

2023 Year 09 Month 08 Day

Anticipated trial start date

2023 Year 09 Month 26 Day

Last follow-up date

2023 Year 11 Month 30 Day

Date of closure to data entry

2023 Year 12 Month 12 Day

Date trial data considered complete

2023 Year 12 Month 19 Day

Date analysis concluded

2025 Year 07 Month 31 Day


Other

Other related information



Management information

Registered date

2023 Year 09 Month 25 Day

Last modified on

2024 Year 07 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059701